Clinical Trial Update: Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial of TAC-302 in patients with detrusor underactivity and overactive bladder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Underactivity
• Overactive Bladder

Drugs mentioned

• TAC-302

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Detrusor Underactivity, Overactive Bladder | Phase 2 | Status: COMPLETED | Results posted: 2025-01-20